Established and novel disease‐modifying treatments in multiple sclerosis
AH Cross, RT Naismith - Journal of internal medicine, 2014 - Wiley Online Library
Multiple sclerosis (MS) is a presumed autoimmune disorder of the central nervous system,
resulting in inflammatory demyelination and axonal and neuronal injury. New diagnostic …
resulting in inflammatory demyelination and axonal and neuronal injury. New diagnostic …
Update on disease-modifying therapies for multiple sclerosis
DL Vargas, WR Tyor - Journal of Investigative Medicine, 2017 - journals.sagepub.com
Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous
system (CNS). It predominantly affects young women and is one of the most common causes …
system (CNS). It predominantly affects young women and is one of the most common causes …
Treatment of multiple sclerosis: current concepts and future perspectives
D Buck, B Hemmer - Journal of neurology, 2011 - Springer
Currently, several disease-modifying therapies for the treatment of multiple sclerosis are
established and more are likely to be introduced. These treatment options differ with respect …
established and more are likely to be introduced. These treatment options differ with respect …
A changing treatment landscape for multiple sclerosis: challenges and opportunities
F Piehl - Journal of internal medicine, 2014 - Wiley Online Library
Multiple sclerosis (MS) is primarily an autoimmune disease of the central nervous system,
but also encompasses prominent neurodegenerative aspects. A significant proportion of MS …
but also encompasses prominent neurodegenerative aspects. A significant proportion of MS …
New and emerging disease modifying therapies for multiple sclerosis
S Saidha, C Eckstein… - Annals of the New York …, 2012 - Wiley Online Library
Several disease‐modifying drugs (DMDs) are currently approved for the treatment of
multiple sclerosis (MS). Recently, there has been increased identification and development …
multiple sclerosis (MS). Recently, there has been increased identification and development …
Update on disease-modifying treatments for multiple sclerosis
MD Carrithers - Clinical therapeutics, 2014 - Elsevier
Purpose The purpose of this review is to discuss the selection and use of disease-modifying
treatments for patients with relapsing forms of multiple sclerosis (MS). Methods PubMed was …
treatments for patients with relapsing forms of multiple sclerosis (MS). Methods PubMed was …
[PDF][PDF] A review of current and emerging therapeutic strategies in multiple sclerosis
MJ Tullman - Am J Manag Care, 2013 - ptce.s3.amazonaws.com
Multiple sclerosis (MS) is a chronic immunemediated disease that potentially requires
symptomatic and disease-modifying therapies. Numerous symptoms (eg, fatigue, spasticity …
symptomatic and disease-modifying therapies. Numerous symptoms (eg, fatigue, spasticity …
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm
BAC Cree, J Mares, HP Hartung - Current opinion in neurology, 2019 - journals.lww.com
Current therapeutic landscape in multiple sclerosis: an evol... : Current Opinion in
Neurology Current therapeutic landscape in multiple sclerosis: an evolving treatment …
Neurology Current therapeutic landscape in multiple sclerosis: an evolving treatment …
Current and emerging treatment of multiple sclerosis.
FM Hart, J Bainbridge - The American journal of managed care, 2016 - europepmc.org
The treatment of multiple sclerosis (MS) falls into 3 categories: treatment of exacerbations,
slowing disease progression with disease-modifying therapies (DMTs), and symptomatic …
slowing disease progression with disease-modifying therapies (DMTs), and symptomatic …
Current and emerging therapies in multiple sclerosis: a systematic review
W Castro-Borrero, D Graves… - Therapeutic …, 2012 - journals.sagepub.com
Multiple sclerosis (MS) is a potentially disabling chronic autoimmune neurological disease
that mainly affects young adults. Our understanding of the pathophysiology of MS has …
that mainly affects young adults. Our understanding of the pathophysiology of MS has …